TTK Prestige Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 7:39 am

Quick Insight

TTK Prestige Ltd, a prominent player in the domestic appliances industry, currently trades at a price of 633 with a market cap of 8,767 Cr. The stock commands a high P/E ratio of 59.5, indicating investor confidence in its growth potential. While the ROE stands at 7.19% and ROCE at 11.6%, the OPM is at 7%, showcasing operational efficiency. With solid reserves of 1,865 Cr and a healthy ICR of 21.20x, the company appears well-positioned for future growth. However, the high P/BV ratio of 4.33x suggests the stock may be overvalued at its current price level, warranting caution for prospective investors.

Competitors of TTK Prestige Ltd

All Competitor Stocks of TTK Prestige Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:00 am

Below is a detailed analysis of the quarterly data for TTK Prestige Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 609.00 Cr.. The value appears to be declining and may need further review. It has decreased from 650.00 Cr. (Mar 2025) to 609.00 Cr., marking a decrease of 41.00 Cr..
• For Expenses, as of Jun 2025, the value is 569.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 598.00 Cr. (Mar 2025) to 569.00 Cr., marking a decrease of 29.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Mar 2025) to 7.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from -55.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 72.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from -26.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 61.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 63.00% (Mar 2025) to 27.00%, marking a decrease of 36.00%.
• For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from -42.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 68.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.92. The value appears strong and on an upward trend. It has increased from -2.93 (Mar 2025) to 1.92, marking an increase of 4.85.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:49 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:10 pm

Below is a detailed analysis of the balance sheet data for TTK Prestige Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,865.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,074.00 Cr. (Mar 2024) to 1,865.00 Cr., marking a decrease of 209.00 Cr..
• For Borrowings, as of Mar 2025, the value is 180.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 180.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 468.00 Cr.. The value appears to be improving (decreasing). It has decreased from 470.00 Cr. (Mar 2024) to 468.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,526.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,737.00 Cr. (Mar 2024) to 2,526.00 Cr., marking a decrease of 211.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 680.00 Cr.. The value appears to be declining and may need further review. It has decreased from 722.00 Cr. (Mar 2024) to 680.00 Cr., marking a decrease of 42.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 23.00 Cr..
• For Investments, as of Mar 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 343.00 Cr. (Mar 2024) to 241.00 Cr., marking a decrease of 102.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,604.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,648.00 Cr. (Mar 2024) to 1,604.00 Cr., marking a decrease of 44.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,526.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,737.00 Cr. (Mar 2024) to 2,526.00 Cr., marking a decrease of 211.00 Cr..

Notably, the Reserves (1,865.00 Cr.) exceed the Borrowings (180.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for TTK Prestige Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.17. This value is within the healthy range. It has decreased from 16.48 (Mar 24) to 8.17, marking a decrease of 8.31.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.16. This value is within the healthy range. It has decreased from 16.48 (Mar 24) to 8.16, marking a decrease of 8.32.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.05. This value is within the healthy range. It has decreased from 20.90 (Mar 24) to 13.05, marking a decrease of 7.85.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.24. It has decreased from 150.48 (Mar 24) to 137.24, marking a decrease of 13.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.24. It has decreased from 150.63 (Mar 24) to 137.24, marking a decrease of 13.39.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 198.30. It has increased from 193.22 (Mar 24) to 198.30, marking an increase of 5.08.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 24.28. This value is within the healthy range. It has decreased from 27.34 (Mar 24) to 24.28, marking a decrease of 3.06.
• For PBIT / Share (Rs.), as of Mar 25, the value is 19.11. This value is within the healthy range. It has decreased from 22.70 (Mar 24) to 19.11, marking a decrease of 3.59.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.75. This value is within the healthy range. It has decreased from 21.73 (Mar 24) to 12.75, marking a decrease of 8.98.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.89. This value is within the healthy range. It has decreased from 16.26 (Mar 24) to 7.89, marking a decrease of 8.37.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 16.48 (Mar 24) to 8.21, marking a decrease of 8.27.
• For PBDIT Margin (%), as of Mar 25, the value is 12.24. This value is within the healthy range. It has decreased from 14.15 (Mar 24) to 12.24, marking a decrease of 1.91.
• For PBIT Margin (%), as of Mar 25, the value is 9.63. This value is below the healthy minimum of 10. It has decreased from 11.74 (Mar 24) to 9.63, marking a decrease of 2.11.
• For PBT Margin (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 10. It has decreased from 11.24 (Mar 24) to 6.43, marking a decrease of 4.81.
• For Net Profit Margin (%), as of Mar 25, the value is 3.97. This value is below the healthy minimum of 5. It has decreased from 8.41 (Mar 24) to 3.97, marking a decrease of 4.44.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.14. This value is below the healthy minimum of 8. It has decreased from 8.53 (Mar 24) to 4.14, marking a decrease of 4.39.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.98. This value is below the healthy minimum of 15. It has decreased from 10.95 (Mar 24) to 5.98, marking a decrease of 4.97.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.71. This value is within the healthy range. It has decreased from 14.07 (Mar 24) to 12.71, marking a decrease of 1.36.
• For Return On Assets (%), as of Mar 25, the value is 4.43. This value is below the healthy minimum of 5. It has decreased from 8.33 (Mar 24) to 4.43, marking a decrease of 3.90.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has increased from 1.00 (Mar 24) to 1.03, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 3.83 (Mar 24) to 3.79, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 2.51. This value exceeds the healthy maximum of 2. It has decreased from 2.74 (Mar 24) to 2.51, marking a decrease of 0.23.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 4. It has decreased from 0.97 (Mar 24) to 0.89, marking a decrease of 0.08.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 36.40 (Mar 24) to 0.00, marking a decrease of 36.40.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.39 (Mar 24) to 0.00, marking a decrease of 28.39.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 63.60 (Mar 24) to 0.00, marking a decrease of 63.60.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.61 (Mar 24) to 0.00, marking a decrease of 71.61.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 21.20. This value is within the healthy range. It has decreased from 28.28 (Mar 24) to 21.20, marking a decrease of 7.08.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.44. This value is within the healthy range. It has decreased from 17.82 (Mar 24) to 12.44, marking a decrease of 5.38.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,592.10. It has decreased from 8,681.05 (Mar 24) to 7,592.10, marking a decrease of 1,088.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.80. This value is within the healthy range. It has decreased from 3.24 (Mar 24) to 2.80, marking a decrease of 0.44.
• For EV / EBITDA (X), as of Mar 25, the value is 22.84. This value exceeds the healthy maximum of 15. It has decreased from 22.91 (Mar 24) to 22.84, marking a decrease of 0.07.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.47 (Mar 24) to 2.99, marking a decrease of 0.48.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 63.59 (Mar 24) to 0.00, marking a decrease of 63.59.
• For Price / BV (X), as of Mar 25, the value is 4.33. This value exceeds the healthy maximum of 3. It has decreased from 4.46 (Mar 24) to 4.33, marking a decrease of 0.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.47 (Mar 24) to 2.99, marking a decrease of 0.48.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness